Product
CKD-386(3)
1 clinical trial
1 indication
Indication
Hypertension and DyslipidemiaClinical trial
An Open Label, Randomized, Single Dose, 2-sequence, 4-period, Cross-over Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-386(3) With Co-administration of D013, D326, and D337 in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2022-06-06